Khosla

Spirent Showcases Advanced Ethernet Validation Solutions at OFC 2024

Retrieved on: 
Tuesday, March 26, 2024
Technology, Mobile, Wireless, Engineering, Manufacturing, 5G, Other Technology, Telecommunications, Software, Networks, Internet, Hardware, Semiconductor, Data Management, Security, AOI, OSFP, Appliance, Khosla, Artificial intelligence, Spirent, CIG, IEEE, QSFP-DD, Product management, Optoelectronics, Ethernet Alliance, 100 Gigabit Ethernet, Partnership, SVP, SPT, Communication, Amphenol, TE Connectivity, M1, LPO, Research, AI, Architecture, Exhibition, AMD, B3, GM, Conference, Environment, LRO, HPC, Ecosystem, Medical device

The latest of its test platforms for validating the reliability, high performance, and interoperability of Ethernet technologies, the B3 Appliance will debut at the 2024 OFC Conference and Exhibition in San Diego, March 26-28 in booth #1515.

Key Points: 
  • The latest of its test platforms for validating the reliability, high performance, and interoperability of Ethernet technologies, the B3 Appliance will debut at the 2024 OFC Conference and Exhibition in San Diego, March 26-28 in booth #1515.
  • As a vendor-neutral test system, the Spirent B3 800G Appliance will help accelerate 800G deployments to enable the networking industry to power new applications running AI/ML.
  • “High density 800G test solutions are critical for validating the performance of 800G modules,” said Gerry Wong, CEO at CIG.
  • In today’s environment, where time-to-market of next-gen solutions is condensed, test and assurance solutions capable of evaluating beta technologies are invaluable.

Spirent and Cadence Collaborate to Bring Advanced Chipset Testing to Pre-Silicon Verification

Retrieved on: 
Tuesday, October 31, 2023
Telecommunications, Networks, Hardware, Electronic Design Automation, Data Management, Technology, Semiconductor, Security, Cloud, Spirent, Khosla, Cadence Design Systems, Inc. v. Avanti Corp, SPT, Comprehensive, Acceleration, Communication, Partnership, LSE, SOC, IP, Protium, Silicon, Video game, Risk management, Printed circuit board, Palladium, Cadence

The collaboration brings sophisticated virtual Ethernet traffic emulation and testing capabilities to pre-silicon verification in the Cadence Palladium® Z2 Enterprise Emulation and Protium™ X2 Enterprise Prototyping systems.

Key Points: 
  • The collaboration brings sophisticated virtual Ethernet traffic emulation and testing capabilities to pre-silicon verification in the Cadence Palladium® Z2 Enterprise Emulation and Protium™ X2 Enterprise Prototyping systems.
  • Jointly developed by Spirent and Cadence, the solution is designed to enable the increasing data bandwidths needed to verify designs for data centers and other high-performance applications.
  • It will help reduce development time, simplify testing of the complex Ethernet chipset design process, and ensure that new products perform as expected.”
    Michael Young, senior product management group director, System and Verification Group at Cadence said: “Through our work with Spirent, Cadence is continuing our commitment to work with industry leaders to bring best-in-class solutions to the pre-silicon verification market.
  • “The new unified test platform reduces testing complexity and accelerates the technology design and development of Ethernet chipsets.”

Stanford University’s Innovative Medicines Accelerator and Intonation Research Laboratories (Intonation) form a collaboration to fight cancerous neuroendocrine tumors

Retrieved on: 
Thursday, June 22, 2023
Health, Genetics, Other Health, Other Science, General Health, Research, Science, Heart, Endocrinology, Partnership, Stanford School, Stanford University, Intonation, Neoplasm, Glomus tumor, Cancer, IMA, Multimedia, Medicine, Doctor of Philosophy, Glioblastoma, Chemistry, Innovative Medicines Initiative, Patient, Chemical engineering, Drug discovery, Marc, Khosla, Ecosystem, Sarafan, Pharmaceutical industry, Management, Symbols of North and East Syria, MD

Stanford University’s Innovative Medicines Accelerator (IMA) and Intonation Research Laboratories (Intonation) have formed a collaboration to develop treatments that target cancerous neuroendocrine tumors, or tumors that form from hormone-releasing cells.

Key Points: 
  • Stanford University’s Innovative Medicines Accelerator (IMA) and Intonation Research Laboratories (Intonation) have formed a collaboration to develop treatments that target cancerous neuroendocrine tumors, or tumors that form from hormone-releasing cells.
  • “I’m excited about this collaboration with Intonation Research Laboratories, which has the potential to speed the translation of promising research into urgently needed new treatments and therapies,” said Marc Tessier-Lavigne , president of Stanford University.
  • “We hope to greatly accelerate our drug development program and deliver transformative treatments to patients burdened with neuroendocrine tumors,” he said.
  • “The IMA continues to seek high-quality partners in our mission as an accelerator,” said Khosla, the Marc and Jennifer Lipschultz Director of the Stanford Innovative Medicines Accelerator.

Realta Fusion Launches with $12 Million in Funding to Develop Fusion Energy

Retrieved on: 
Wednesday, May 31, 2023
U.S. Department of Energy, Office of Inspector General, University, U.S. Department of Defense Strategy for Operating in Cyberspace, Fusion, Temperature, WARF, ARPA, Wind, University of Wisconsin–Madison, Plasma, Professor, Wisconsin Alumni Research Foundation, Khosla Ventures, Physics, Khosla, BEAM, Lithium, Renewable energy, Rodels-Realta railway station

MADISON, Wis., May 31, 2023 /PRNewswire-PRWeb/ -- Realta Fusion, a new startup in fusion energy, today announced $12 million in financing to develop compact magnetic mirror fusion technology. The company raised a seed investment of $9 million led by Khosla Ventures and received an award of $3 million from the US Department of Energy's Fusion Development Program. The Wisconsin Alumni Research Foundation (WARF), through which Realta licensed its core technology, also participated in the seed round.

Key Points: 
  • Realta Fusion announces $12 million in funding, consisting of a $9 million seed round led by Khosla Ventures and a $3M award from the U.S. Department of Energy.
  • MADISON, Wis., May 31, 2023 /PRNewswire-PRWeb/ -- Realta Fusion, a new startup in fusion energy, today announced $12 million in financing to develop compact magnetic mirror fusion technology.
  • The company raised a seed investment of $9 million led by Khosla Ventures and received an award of $3 million from the US Department of Energy's Fusion Development Program.
  • In Realta, we saw a team that has made significant technical advances and can iterate quickly and cost-effectively to get to commercial fusion energy."

Kindred, Members-Only Home Swapping Network, Announces 5,000 Nights Swapped and Series A Funding to Revolutionize the Sharing Economy

Retrieved on: 
Wednesday, April 19, 2023
Technology, Construction & Property, Architecture, Transportation, Lodging, Destinations, Vacation, Travel, Consumer Electronics, Life, NEA, Series, Host, City, Growth, New Enterprise Associates, Tourism, Cryptocurrency, Kindred, Khosla

Kindred, the members-only home swapping network, announced today the successful completion of its Series A funding round at $15 million.

Key Points: 
  • Kindred, the members-only home swapping network, announced today the successful completion of its Series A funding round at $15 million.
  • The recent funding round showcases the potential of the give-to-get sharing economy to make travel a way of life.
  • Kindred Members have spent over 5,000 nights at one another’s homes, and both Host and Guest Satisfaction scores are above 9 out of 10.
  • We're excited to use this funding to continue to grow our network while maintaining a strong experience for our members."

Tavant and Bayer Enter into an Innovative AgriTech Partnership to Transform Sustainable Farming Practices

Retrieved on: 
Wednesday, March 15, 2023
Data Management, Technology, Agriculture, Natural Resources, Software, Artificial Intelligence, Internet, Cloud, Silicon, Millionaire (Cash Cash and Digital Farm Animals song), Bayer, Khosla, Climate, Artificial intelligence, Partnership, Internet of things, Agricultural technology, Data, Organization, Food, Knowledge, Weather, Machine learning, Hitech, Tavant

The partnership comes at a crucial time when growers face mounting pressure to increase productivity while confronting many challenges beyond their control, such as unpredictable weather events and unstable commodity markets.

Key Points: 
  • The partnership comes at a crucial time when growers face mounting pressure to increase productivity while confronting many challenges beyond their control, such as unpredictable weather events and unstable commodity markets.
  • With a focus on enhancing transparency and promoting sustainability throughout the food supply chain, this collaboration is set to transform the agricultural industry.
  • "Innovation in digital agriculture is critical for achieving sustainable farming practices and ensuring adequate food supply.
  • Over the past two decades, Tavant has invested significantly in developing sustainable and efficient farming practices.

Array Named to Prestigious Embedded Fintech 50 List

Retrieved on: 
Wednesday, February 1, 2023
Insurance, Finance, Marketing, Banking, Communications, Professional Services, Fintech, Business, Benchmark, GGV Capital, QED, Khosla, Sequoia, ICONIQ, Founders Fund, GGV, Embedded, Bell, Privacy, European Closing Bell, Growth, Financial management, IVP, Cryptocurrency, Array, Thrive

Array announced today its inclusion on GGV Capital’s Embedded Fintech 50 list, which recognizes the industry’s most promising B2B financial services platform companies as judged by the world’s top startup investors.

Key Points: 
  • Array announced today its inclusion on GGV Capital’s Embedded Fintech 50 list, which recognizes the industry’s most promising B2B financial services platform companies as judged by the world’s top startup investors.
  • “Being named to GGV’s Embedded Fintech 50 list is a testament to the need for fintech solutions like ours that build enduring trust between consumers and the companies they rely on to streamline their personal financial management,” said Martin Toha, CEO and Co-founder of Array.
  • Having raised more than $12 billion collectively, the Embedded Fintech 50 companies demonstrate the enthusiasm of venture capital investors in the growth and innovation of this sector.
  • “We are excited for the continued development of the embedded fintech landscape and further creative innovations to come.”
    The recognition by GGV comes after a year of tremendous growth for Array.

Genecis Raises US$10 Million in Funding to Commercialize Biodegradable Plastic Products

Retrieved on: 
Thursday, August 4, 2022
Cloud, Y Combinator, Carbon, CEO, Khosla, Technology, Plastic, Agriculture, Silicon, Plant, Textile, BDC, Silicon Valley Bank, Petroleum, Food, Polyhydroxyalkanoates, Khosla Ventures, Fermentation, Foodservice, PHA, Recycling, Renewable energy

Toronto, Ontario--(Newsfile Corp. - August 4, 2022) - Genecis Bioindustries Inc. ("Genecis") announced that it has raised US$7 million in Series A funding led by Khosla Ventures and BDC Capital's Cleantech Practice.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - August 4, 2022) - Genecis Bioindustries Inc. ("Genecis") announced that it has raised US$7 million in Series A funding led by Khosla Ventures and BDC Capital's Cleantech Practice.
  • Genecis has also secured a US$3 million credit facility from Silicon Valley Bank, subject to customary closing conditions.
  • PHAs (polyhydroxyalkanoates) are recognized as the only biodegradable polymers that can mimic the useful functional properties of petroleum plastics.
  • "The funding will allow us to advance in our commercialization efforts and bring forth the next generation of sustainable plastics."

Anagenex Closes $30 Million Series A Round led by Catalio to Advance Small Molecule Drug Discovery with a Novel, Directed Evolution Platform

Retrieved on: 
Wednesday, June 8, 2022
Technology, Genetics, Nanotechnology, Clinical Trials, Biotechnology, Other Health, Health, Pharmaceutical, General Health, Â, Lux Capital, Series, LinkedIn, CEO, Khosla, Algorithm, Machine learning, FDA, Norwest Venture Partners, Patient, Khosla Ventures, Twitter, Industry, Drug discovery, Menlo Ventures, Efficiency, Dels, Biochemistry, General partnership, Pharmaceutical industry, Fine chemical, San Francisco Bay

The Anagenex platform iteratively assesses up to billions of compounds in parallel to generate extraordinarily high quality data.

Key Points: 
  • The Anagenex platform iteratively assesses up to billions of compounds in parallel to generate extraordinarily high quality data.
  • Anagenexs directed evolution platform has also identified small molecule compounds for a validated undruggable target.
  • Anagenex is a pre-clinical biotechnology innovator advancing drug discovery through its small molecule directed evolution platform.
  • The companys unique, machine learning-driven technology enables Anagenex to discover first-in-class and best-in-class small molecule medicines addressing historically intractable targets.

Consumers and Employees Call for a New Approach to Corporate Philanthropy: Stakeholder Philanthropy

Retrieved on: 
Tuesday, May 17, 2022
Human, Interest, Solution, Software, Corporation, Engagement, Consumer, Employment, Khosla, Benevity, Organization, GLOBE, Public relations, Pharmaceutical industry

The findings highlight a growing interest in and expectation of employees and consumers to be involved in corporate philanthropy and call on businesses to consider a new approach that is more stakeholder driven.

Key Points: 
  • The findings highlight a growing interest in and expectation of employees and consumers to be involved in corporate philanthropy and call on businesses to consider a new approach that is more stakeholder driven.
  • Furthermore, 84% of consumers and 85% of employees say the more a business engages its consumers and employees in charitable giving decisions, the more trust they have in that business.
  • 84% of consumers agree that the more a business engages its consumers and employees in its decisions on charitable giving, the more trust consumers have in that business.
  • As stakeholder capitalism takes root, stakeholder philanthropy is clearly emerging as a new trend in corporate giving.